首页 > 市场调查报告书 > 医疗设备

病患监测

市场调查报告书

商品编码

1643894

全球无袖血压监测设备市场 - 2025-2033

Global Cuffless Blood Pressure Monitoring Devices Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 246 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球无袖血压监测设备市场规模达到6.8117亿美元，预计2033年将达到17.315亿美元，2025-2033年预测期间复合年增长率为10.7%。

无袖血压计是具有多种用途的多种设备，但它们面临特定的准确性问题，使得既定的验证协议不够充分。验证应解决个人袖带校准、测量稳定性、血压变化追踪和机器学习实施的问题。也可以考虑进行临床现场调查来解决无袖血压读数的临床实施问题。

市场动态：

驱动程式和限制

不断进步的技术

感测器技术、人工智慧和机器学习的不断进步正在推动准确、非侵入性无袖血压计的开发。随着物联网技术的融合，远端监控和远距医疗应用进一步增强。小型化和多功能将使这些设备能够嵌入智慧手錶和健身追踪器等可穿戴产品中。这些发展使用户对设备更加舒适并提高依从性，将他们引入慢性病管理和预防性医疗保健的日常工作中，从而导致市场成长。

例如，2024 年 11 月，CART BP 是世界上第一款专为连续血压监测而设计的无袖带环形设备，由韩国健康科技新创公司 Sky Labs 申请专利。与普通腕式智慧手錶不同，CART BP 透过光电体积描记法 (PPG) 提供更稳定的讯号，从而准确读取流经手指的血流量。考虑到手腕尺寸的差异和感测器的机械未对准，手腕分布式设备通常精度较差。

因此，这项创新在市场上树立了新的基准，推动了对更可靠和用户友好的监控解决方案的需求，这是帮助市场在预测期内成长的进步因素之一。

监管挑战

全球无袖血压监测设备市场受到监管挑战的阻碍。医疗器材的审批流程因地区而异，为製造商创造了一个复杂的环境。缺乏统一的全球标准可能会导致产品开发的延迟、成本的增加以及新感测器的上市时间。监管政策的变化或不一致也会扰乱市场，使製造商难以维持一致的产品供应。因此，无袖血压监测设备的推出减缓了整个产业的成长。

Omron
CardiacSense
Valencell, Inc
Aktiia SA
Equate Health
Healthstats International Pte. Ltd.
Corsano Health
SOMNOmedics AG
LiveMetric
Similar data will be provided for each market player.
索姆诺医疗有限公司
- 管道产品说明
- 产品关键绩效指标 (KPI)
- 主要活动
- 市场进入时间表
- 产品渗透率
- 销售估算与预测
安德医疗
华为终端有限公司
将为每个市场参与者提供类似的资料。

第 12 章：附录

简介目录

Product Code: MD9058

The global cuffless blood pressure monitoring devices market reached US$ 681.17 million in 2024 and is expected to reach US$ 1731.5 million by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033.

Cuffless blood pressure monitors are a diverse group of devices with various uses, but they face specific accuracy issues, making established validation protocols inadequate. Validation should address individual cuff calibration, measurement stability, BP change tracking, and machine learning implementation. Clinical field investigations may also be considered to address clinical implementation issues of cuffless BP readings.

Market Dynamics: Drivers & Restraints

Increasing Technological Advancements

The ongoing advancements in sensor technology, artificial intelligence, and machine learning are leading to the development of accurate, non-invasive cuffless blood pressure monitors. With the integration of IoT technologies, remote monitoring and telemedicine applications are further enhanced. Miniaturization and multi-functionality will enable these devices to be embedded in wearable products such as smartwatches and fitness trackers. These developments make users more comfortable with the device and increase compliance, introducing them into the daily routine in chronic disease management and preventive health care and subsequently causing market growth.

For instance, in November 2024, CART BP is the first-ever cuffless ring-shaped device in the world designed for continuous blood pressure monitoring, patented by a health tech startup in South Korea, Sky Labs. Unlike ordinary wrist-based smart watches, CART BP provides more stable signals from photoplethysmography (PPG) to offer an accurate reading of blood flow through the finger. Wrist-distributed devices typically suffer from poor accuracy, considering differences in wrist sizes and mechanical misalignment of sensors.

Hence, this innovation sets a new benchmark in the market, driving demand for more reliable and user-friendly monitoring solutions which is one of the factor of advancements that helps the market to grow during the forecast period.

Regulatory Challenges

The global cuffless blood pressure monitoring devices market is hindered by regulatory challenges. The approval process for medical devices varies across regions, creating a complex landscape for manufacturers to navigate. This lack of uniform global standards can lead to delays in product development, increased costs, and time-to-market for new sensors. Changes or inconsistencies in regulatory policies can also disrupt the market, making it difficult for manufacturers to maintain consistent product offerings. As a result, the introduction of Cuffless Blood Pressure Monitoring Devices slows overall industry growth.

Segment Analysis

The global cuffless blood pressure monitoring devices market is segmented based on product type, technology, application, end user and region.

Product Type:

Wrist-based segment is expected to dominate the Cuffless Blood Pressure Monitoring Devices market share

The wrist-based segment holds a major portion of the cuffless blood pressure monitoring devices market share and is expected to continue to hold a significant portion of the cuffless blood pressure monitoring devices market share during the forecast period.

Cuffless blood pressure monitoring is one domain, in which wrist-based devices find their highest contribution in the global marketing space, making themselves all so convenient and portable that they can be integrated with wearable technologies. These devices also possess the advantage of neither storage nor continuous blood pressure monitoring, making them quite appealing to medical and consumer needs. The evolution that smartwatches have made from newly introduced fitness trackers with blood pressure sensors can act as factors that drive the advancement powered by the various improvements made in optical and piezoelectric sensing technologies. The other driving factors in the market would be the product launches, increasing demand for multipurpose wearables, unifying health monitoring with lifestyle features and other various factors.

For instance, in August 2023, Corsano Health announced that it has successfully integrated cuffless blood pressure measurements into its new generation smart bracelet. cardiowatch 287-2 is a wireless and remote patient monitoring solution that collects continuous physiological data from the home and health facility, including heart rate, heart rate variability (R-R interval), respiration rate, activity, sleep, ECG, SpO2, body temperature, and blood pressure.

End User:-

Hospitals segment is the fastest-growing segment in Cuffless Blood Pressure Monitoring Devices market share

The hospitals segment is the fastest-growing segment in the cuffless blood pressure monitoring devices market share and is expected to hold the market share over the forecast period.

Hospitals are sure catalyzers for the growth of the global cuffless blood pressure monitoring device markets, making available possibilities for continuous, non-invasive blood pressure monitoring. Such devices further enhance patient comfort during long-term or post-surgical recovery because they provide automated blood pressure recording and data capture on an on-going basis. Data transmission in real-time allows the identification of blood pressure deviations earlier enough to permit intervention by a healthcare provider. Incorporating cuffless devices into EHR systems boosts workflow efficiency and improves personalized patient care.

As more hospitals adopt telemedicine solutions, cuffless blood pressure monitors will be essential for remote patient monitoring programs to have care continuity and decrease readmission numbers. The segment is consequently critical for clinically competent and technologically advanced solutions.

Geographical Analysis

North America is expected to hold a significant position in the Cuffless Blood Pressure Monitoring Devices market share

North America holds a substantial position in the cuffless blood pressure monitoring devices market and is expected to hold most of the market share due to product launches, FDA clearance, advanced healthcare infrastructure and high healthcare expenditure. The rising prevalence of hypertension and cardiovascular diseases, coupled with an aging population, drives demand for innovative solutions. Technological advancements in wearable devices, telemedicine adoption, and home healthcare are key drivers. Strong regulatory frameworks, such as FDA approvals for cuffless devices, and growing consumer awareness about preventive health and wellness fuel market expansion in North America.

For instance, in January 2024, Nanowear is announced to be a front-runner in remote diagnostics for bringing health care home when it announced that its "nanotechnology-enabled wearable and software platform - SimpleSense has received FDA 510(k) clearance for a novel AI-enabled Software-as-a-MedicalDevice (SaMD). As the first non-invasive, cuffless continuous blood pressure monitor and diagnostics, SimpleSense BP is transforming a clinical diagnostic tool in the diagnostic management of hypertension and adds to the cardiopulmonary diagnostics previously cleared for the wearable platform.

Moreover, according to National Center for Health Statistics, in U.S Hypertension prevalence increases with age, with 23.4% in adults aged 18-39, 52.5% for 40-59, and 71.6% for 60 and older. Both men and women show a similar pattern, with higher prevalence in men aged 18-39 (30.0% compared to 16.4%) and 55.9% for 40-59, but not significantly different between men and women aged 60 and older.

Europe is growing at the fastest pace in the Cuffless Blood Pressure Monitoring Devices market

Europe holds the fastest pace in the cuffless blood pressure monitoring devices market and is expected to hold most of the market share due to growing focus on preventive healthcare and chronic disease management. The aging population and rising hypertension incidence drive demand for user-friendly monitoring solutions. Government initiatives, stringent regulatory standards, and collaborations between medical device companies and academic institutions contribute to growth. The integration of these devices into hospital systems and consumer wearables accelerates adoption across the region.

For instance, National Health Service, High blood pressure or hypertension is common among adults across the UK, at about one in three. In England, 31% of men have this condition, compared to 26% of women and up to six million across the UK, as described by Blood Pressure UK.

Hence, the high prevalence of hypertension among adults in the UK further demonstrates the importance of convening and accessible blood pressure monitoring technologies. Cuffless blood pressure monitoring devices facilitate continuous, non-invasive tracking of blood pressure for the convenience of users in self-managing their health. This development will contribute to market growth in line with the increasing emphasis by the UK on preventive healthcare and awareness campaigns for hypertension.

Competitive Landscape

The major global players in the cuffless blood pressure monitoring devices market include Biobeat Technologies, Omron, CardiacSense, Valencell, Inc, Aktiia SA, Equate Health, Healthstats International Pte. Ltd., Corsano Health, SOMNOmedics AG, LiveMetric and among others.

Key Developments

In November 2024, Movano Health Inc. has undergone testing its novel blood pressure wrist-worn instrument during its clinical trials which held at the University of California San Francisco on the 5th and 6th of November for hypoxia. The new device comes with added 12mm wave antennas which, in conjunction with Movano Health's custom IC, provide greater data collection versatility with reduced placement effects, along with a thinner form factor, making it easier to wear with comfort.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global cuffless blood pressure monitoring devices market report delivers a detailed analysis with 68+ key tables, more than 80 visually impactful figures, and 246 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Regulatory Challenges
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Wrist-based*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Finger-based Monitors
6.4. Armband-based Monitors

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Pulse Transit Time (PTT) Technology*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Optical Technology
7.4. Volume Clamp Technology
7.5. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Hypertension Management*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hypotension Management
8.4. Cardiovascular Risk Assessment
8.5. Remote Patient Monitoring

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Home Care Settings
9.4. Clinics
9.5. Diagnostic Centers

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

12.1. Biobeat Technologies*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
  - 12.1.2.1. Product Description
  - 12.1.2.2. Product Key Performance Indicators (KPIs)
  - 12.1.2.3. Historic and Forecasted Product Sales
  - 12.1.2.4. Product Sales Volume
- 12.1.3. Financial Overview
  - 12.1.3.1. Company Revenue's
  - 12.1.3.2. Geographical Revenue Shares
  - 12.1.3.3. Revenue Forecasts
- 12.1.4. Key Developments
  - 12.1.4.1. Mergers & Acquisitions
  - 12.1.4.2. Key Product Development Activities
  - 12.1.4.3. Regulatory Approvals etc.
- 12.1.5. SWOT Analysis
12.2. Omron
12.3. CardiacSense
12.4. Valencell, Inc
12.5. Aktiia SA
12.6. Equate Health
12.7. Healthstats International Pte. Ltd.
12.8. Corsano Health
12.9. SOMNOmedics AG
12.10. LiveMetric
Similar data will be provided for each market player.

Emerging Market Players

12.11. SOMNOmedics GmbH*
- 12.11.1. Pipeline Products Description
- 12.11.2. Product Key Performance Indicators (KPIs)
- 12.11.3. Key Activities
- 12.11.4. Market Entry Timelines
- 12.11.5. Product Penetration Rate
- 12.11.6. Sales Estimation and Projections
12.12. A&D Medical
12.13. Huawei Device Co., Ltd.
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE